| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 527.67 Million | USD 853 Million | 4.92% | 2024 |
FrequentlyAsked Questions
Nisin is a small molecule polypeptide antibiotic possessing anti-microbial effect produced & released at time of metabolism by Lactococcus lactic subsp.
The global nisin market is expected to grow due to increasing clean-label food trends, rising demand for natural food preservatives, growth in processed food consumption, and stringent regulations against synthetic preservatives.
According to a study, the global nisin market size was worth around USD 527.67 Million in 2024 and is expected to reach USD 853 Million by 2034.
The global nisin market is expected to grow at a CAGR of 4.92% during the forecast period.
Europe is expected to dominate the nisin market over the forecast period.
Leading players in the global nisin market include Galactic, Siveele B.V., Santa Cruz Biotechnology Inc., .Cayman Chemical Company, Duke Thomson's India Pvt. Ltd., Merck Group, .Chihon Biotechnology Co. Ltd., Mayasan Biotech, DuPont de Nemours Inc., Royal DSM, among others.
The report explores crucial aspects of the nisin market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients